These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 34423789)

  • 1. A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Hoel F; Hoel A; Pettersen IK; Rekeland IG; Risa K; Alme K; Sørland K; Fosså A; Lien K; Herder I; Thürmer HL; Gotaas ME; Schäfer C; Berge RK; Sommerfelt K; Marti HP; Dahl O; Mella O; Fluge Ø; Tronstad KJ
    JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34423789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism.
    Germain A; Ruppert D; Levine SM; Hanson MR
    Mol Biosyst; 2017 Jan; 13(2):371-379. PubMed ID: 28059425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID).
    Huth TK; Eaton-Fitch N; Staines D; Marshall-Gradisnik S
    J Transl Med; 2020 May; 18(1):198. PubMed ID: 32404171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioenergetic and Proteomic Profiling of Immune Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients: An Exploratory Study.
    Fernandez-Guerra P; Gonzalez-Ebsen AC; Boonen SE; Courraud J; Gregersen N; Mehlsen J; Palmfeldt J; Olsen RKJ; Brinth LS
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review.
    Tomas C; Newton J
    Biochem Soc Trans; 2018 Jun; 46(3):547-553. PubMed ID: 29666214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered Fatty Acid Oxidation in Lymphocyte Populations of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Maya J; Leddy SM; Gottschalk CG; Peterson DL; Hanson MR
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulated Provision of Oxidisable Substrates to the Mitochondria in ME/CFS Lymphoblasts.
    Missailidis D; Sanislav O; Allan CY; Smith PK; Annesley SJ; Fisher PR
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment.
    Cabanas H; Muraki K; Eaton-Fitch N; Staines DR; Marshall-Gradisnik S
    Front Immunol; 2021; 12():687806. PubMed ID: 34326841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise modifies glutamate and other metabolic biomarkers in cerebrospinal fluid from Gulf War Illness and Myalgic encephalomyelitis / Chronic Fatigue Syndrome.
    Baraniuk JN; Kern G; Narayan V; Cheema A
    PLoS One; 2021; 16(1):e0244116. PubMed ID: 33440400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.
    Helliwell AM; Sweetman EC; Stockwell PA; Edgar CD; Chatterjee A; Tate WP
    Clin Epigenetics; 2020 Nov; 12(1):167. PubMed ID: 33148325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.
    Morris G; Maes M
    Metab Brain Dis; 2014 Mar; 29(1):19-36. PubMed ID: 24557875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics.
    Nagy-Szakal D; Barupal DK; Lee B; Che X; Williams BL; Kahn EJR; Ukaigwe JE; Bateman L; Klimas NG; Komaroff AL; Levine S; Montoya JG; Peterson DL; Levin B; Hornig M; Fiehn O; Lipkin WI
    Sci Rep; 2018 Jul; 8(1):10056. PubMed ID: 29968805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
    Maes M; Twisk FN; Ringel K
    Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME).
    Lupo GFD; Rocchetti G; Lucini L; Lorusso L; Manara E; Bertelli M; Puglisi E; Capelli E
    Sci Rep; 2021 Mar; 11(1):7043. PubMed ID: 33782445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN
    PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients.
    Missailidis D; Annesley SJ; Allan CY; Sanislav O; Lidbury BA; Lewis DP; Fisher PR
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of GDF15 in patients with myalgic encephalomyelitis/chronic fatigue syndrome.
    Melvin A; Lacerda E; Dockrell HM; O'Rahilly S; Nacul L
    J Transl Med; 2019 Dec; 17(1):409. PubMed ID: 31801546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    de Vega WC; Herrera S; Vernon SD; McGowan PO
    BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease.
    Holden S; Maksoud R; Eaton-Fitch N; Cabanas H; Staines D; Marshall-Gradisnik S
    J Transl Med; 2020 Jul; 18(1):290. PubMed ID: 32727475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-'omics of gut microbiome-host interactions in short- and long-term myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Xiong R; Gunter C; Fleming E; Vernon SD; Bateman L; Unutmaz D; Oh J
    Cell Host Microbe; 2023 Feb; 31(2):273-287.e5. PubMed ID: 36758521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.